A Kaplan–Meier plotter revealed that TNBC with high TLR3 expression had a better prognosis than breast cancer with low TLR3 expression (Fig. 1D, p = 0.042) in the FUSCC TNBC cohort. This evidence concerns the gene TLR3 and breast carcinoma.